1. Food and Drug Administration. FDA approves higher dosage of naloxone nasal spray to treat opioid overdose. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-higher-dosage-naloxone-nasal-spray-treat-opioid-overdose
2. Food and Drug Administration. FDA Advisory Committee on the most appropriate dose or doses of naloxone to reverse the effects of life-threatening opioid overdose in the community settings. Joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2023. https://www.fda.gov/media/100409/download
3. The role of science in addressing the opioid crisis.;Volkow;N Engl J Med,2017
4. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.;Abdelal;Harm Reduct J,2022
5. Naloxone administration by law enforcement officers in New York State (2015–2020).;Pourtaher;Harm Reduct J,2022